ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

XLO Xilio Therapeutics Inc

0.5821
0.0321 (5.84%)
24 Feb 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -19.56M-21.22M-24.55M-20.21M-23.17M-23.53M-20.12M-17.36M
Pre Tax Income -19.7M-21.35M-24.61M-19.79M-22.47M-22.65M-19.36M-16.75M
Net Income -19.7M-21.35M-24.61M-19.79M-22.47M-22.65M-19.36M-16.75M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -19.7M-21.35M-24.61M-19.98M-22.47M-22.65M-19.36M-16.75M
EBITDA -19.06M-20.78M-24.19M-19.65M-22.83M-23.03M-19.72M-16.81M
Year End 31 December 2022 2019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0000
Operating Income -19.03M-54.56M-75.04M-89.15M
Pre Tax Income -17.31M-55.22M-75.8M-88.22M
Net Income -17.31M-55.22M-75.8M-88.22M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) 0-8.424-2.771-3.217
EBIT -17.31M-55.22M-75.8M-88.22M
EBITDA -18.79M-53.5M-73.55M-87.45M

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com